We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL... Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others. Show more
Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25 Deepening responses observed over time in Descartes-08-treated participants in Phase 2b trial in myasthenia...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.05 | 6.07638888889 | 17.28 | 18.33 | 16.4 | 139535 | 17.18643721 | CS |
4 | -0.57 | -3.01587301587 | 18.9 | 20.295 | 16.4 | 150926 | 18.23276482 | CS |
12 | -4.06 | -18.1330951318 | 22.39 | 26.5 | 15.5 | 125539 | 19.28046303 | CS |
26 | 0.95 | 5.46605293441 | 17.38 | 26.5 | 12.48 | 111620 | 18.28632712 | CS |
52 | -5.67 | -23.625 | 24 | 41.87 | 11.665 | 247365 | 20.00511524 | CS |
156 | -5.865 | -24.2405455673 | 24.195 | 42.6 | 11.665 | 364731 | 22.65343807 | CS |
260 | -5.865 | -24.2405455673 | 24.195 | 42.6 | 11.665 | 364731 | 22.65343807 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions